Omnicell (OMCL) EBIT (2010 - 2026)

Omnicell (OMCL) has 17 years of EBIT data on file, last reported at $16.9 million in Q1 2026.

• On a quarterly basis, EBIT rose 245.06% year-over-year to $16.9 million in Q1 2026; TTM through Mar 2026 was $33.6 million, a 218.34% increase from a year earlier, with the FY2025 full-year figure at $5.2 million, up 1431.16% from the prior year.
• EBIT for Q1 2026 stood at $16.9 million, up from $415000.0 in the prior quarter.
• Over the last five years, EBIT for OMCL reached as high as $18.5 million in Q3 2022 and fell as low as -$38.4 million in Q4 2022.
• Historically, EBIT has averaged -$872941.2 across 5 years, with a median of $5.1 million in 2022.
• Across the five-year window, EBIT sank 551.67% in 2023 and jumped 245.06% in 2026, its largest moves.
• Year by year, EBIT stood at -$38.4 million in 2022, then surged by 39.09% to -$23.4 million in 2023, then soared by 153.05% to $12.4 million in 2024, then sank by 96.65% to $415000.0 in 2025, then surged by 3961.2% to $16.9 million in 2026.
• Per Business Quant data, the three most recent EBIT figures were $16.9 million in Q1 2026, $415000.0 in Q4 2025, and $8.2 million in Q3 2025.